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Abstract
Metabolic syndrome (MetS) has become a health and financial burden worldwide. The MetS
definition captures clustering of risk factors that predict higher risk for diabetes mellitus and
cardiovascular disease. Our study hypothesis is that additional to genes influencing individual
MetS risk factors, genetic variants exist that influence MetS and inflammatory markers forming a
predisposing MetS genetic network. To test this hypothesis a staged approach was undertaken. (a)
We analyzed 17 metabolic and inflammatory traits in more than 85,500 participants from 14 large
epidemiological studies within the Cross Consortia Pleiotropy Group. Individuals classified with
MetS (NCEP definition), versus those without, showed on average significantly different levels
for most inflammatory markers studied. (b) Paired average correlations between 8 metabolic traits
and 9 inflammatory markers from the same studies as above, estimated with two methods, and
factor analyses on large simulated data, helped in identifying 8 combinations of traits for follow-
up in meta-analyses, out of 130,305 possible combinations between metabolic traits and
inflammatory markers studied. (c) We performed correlated meta-analyses for 8 metabolic traits
and 6 inflammatory markers by using existing GWAS published genetic summary results, with
about 2.5 million SNPs from twelve predominantly largest GWAS consortia. These analyses
yielded 130 unique SNPs/genes with pleiotropic associations (a SNP/gene associating at least one
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metabolic trait and one inflammatory marker). Of them twenty-five variants (seven loci newly
reported) are proposed as MetS candidates. They map to genes MACF1, KIAA0754, GCKR,
GRB14, COBLL1, LOC646736-IRS1, SLC39A8, NELFE, SKIV2L, STK19, TFAP2B, BAZ1B,
BCL7B, TBL2, MLXIPL, LPL, TRIB1, ATXN2, HECTD4, PTPN11, ZNF664, PDXDC1, FTO,
MC4R and TOMM40. Based on large data evidence, we conclude that inflammation is a feature of
MetS and several gene variants show pleiotropic genetic associations across phenotypes and might
explain a part of MetS correlated genetic architecture. These findings warrant further functional
investigation.
INTRODUCTION
Metabolic syndrome (MetS) is a constellation of medical conditions that include abdominal
obesity with visceral fat deposition, atherogenic dyslipidemia (high triglyceride and low
high density lipoprotein cholesterol levels), hyperglycemia and/or insulin resistance, and
high blood pressure [1]. Due to the rise in obesity rates and poor dietary habits, MetS has
become an increasing public health and financial burden [2–7]. MetS is associated with at
least five-fold increased risk in developing diabetes mellitus (T2D) and two-fold increased
heart disease risk [5]. Recently, it was reported that individuals with acute ischemic stroke
and metabolic syndrome have increased inflammation and arterial stiffness [8, 9]. Overall
MetS captures a confluence of clinical disorders, assisting front-line practitioners in
identifying cardiovascular and metabolic risk factors requiring simultaneous clinical
attention [1, 10].
There are differing ideas regarding the genetic etiology and cardiovascular sequelae of
MetS, including whether the MetS components are independent in origin or share common
determinants. At the phenotypic level, the increased cardiovascular disease (CVD) risk
associated with MetS appears to be no greater than the sum of its single traits’ risk [11, 12].
Individuals with MetS, often exhibit a pro-inflammatory state, with increased levels of C-
reactive protein, white blood cell count, coagulation factors VII, VIII and fibrinogen, von
Willebrand factor, plasminogen activator inhibitor 1, soluble vascular adhesion molecules
such as intercellular adhesion molecule 1 (ICAM-1), P-selectin as well as decreased levels
of adiponectin [13–17]. It has been suggested that modified cytokine expression associating
a greater volume of adipose tissue may be a mechanism for the low grade inflammation
accompanying dysregulated lipid and glucose metabolism, as well as blood pressure [13, 18,
19]. Henneman et al. [12] recommended the genetic dissection of MetS be approached by
studying individual components, because of their high heritability. Currently, it remains
unclear whether genetic variants identified for individual metabolic traits [20–24] and
inflammatory markers [25–29], have pleiotropic effects, thereby influencing the correlated
architecture of these traits. Dallmeier et al. [30] suggested that the relationship between
MetS and a number of inflammatory markers is largely accounted for by the individual
MetS components, and MetS as a construct generally is no more than the sum of its parts
with respect to inflammation. We propose that in addition to genes influencing individual
MetS risk factors, there are genetic variants that influence MetS risk factors and
inflammatory markers, forming a pleiotropic intertwined genetic network. As part of the
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“Pleiotropy among Metabolic traits and Inflammatory-prothrombotic markers” working
group, a sub-group of the Cross Consortia Pleiotropy Group, we aimed to: (a) evaluate
epidemiological associations between MetS and inflammatory markers; (b) assess
correlations among metabolic traits and inflammatory markers for identifying combinations
to explore for potentially genetic pleiotropic associations and pathways; (c) utilize these
newly identified trait-combinations to perform correlated meta-analyses using previously
published GWAS meta-results from large consortia for the individual traits, with the overall
goal of detecting MetS candidates with potential pleiotropic effects across metabolic traits
and inflammatory markers.
MATERIALS AND METHODS
A Brief Summary of Implemented Methods
The international collaboration of Cross Consortia Pleiotropy Group (XC-Pleiotropy) was
founded in the early 2011 for studying pleiotropy by using published GWAS results. The
PMI-WG is a collaborative group within the XC-Pleiotropy (Supplement 1). For
implementing the first two aims (see Introduction), 17 metabolic traits and inflammatory
markers are studied (Methods.1), from 14 large-scale cohort studies (dependent on cohort-
specific assay availability, Table 1.a and Supplement 2). Together these data represent more
than 85,500 individuals (Supplemental Table 1). Laboratory methods for obtaining these
traits are described in Supplement 2. Traits adjustments for medication use and other
covariates are provided in Methods.2. Methods of estimating correlations with simulations
and Fisher’s Z-transformation are provided in Methods.3, and factor analysis in Methods.4.
Each study was approved by its local ethics board and each participant provided written,
informed consent.
For implementing the third aim (see Introduction), we utilized published full results from
mainly GWAS meta-analyses consortia (Table 1.b). We performed meta-analyses taking
correlation among results into consideration [31, 32] (Methods.5) for identifying pleiotropic
variants for metabolic traits and inflammatory markers. In this paper, a leading SNP and its
mapped gene are considered pleiotropic when the SNP associates with at least a metabolic
trait and an inflammatory marker and passes the meta-analysis threshold. In this framework,
our study includes published results for body mass index (BMI) [23], waist circumference
(WAIST) [33], high density lipoprotein cholesterol (HDLC) and triglycerides (TG) [24],
fasting glucose (GLUC) and fasting insulin (INS) [20], systolic and diastolic blood pressure
(SBP, DBP) [22]. In addition, our meta-analyses included inflammatory markers, C-reactive
protein (CRP) [25], plasminogen activator inhibitor 1 (PAI-1) [26], white blood cell counts
(WBCC) [27], adiponectin (ADIP) [34], intercellular adhesion molecule 1 (ICAM-1) [28],
and interleukin 6 (IL-6) [35]. Because interleukin 10 (IL-10) was not significantly correlated
with other traits, and fibrinogen (FIB) and tumor necrosis factor alpha (TNFA) meta-
analyses GWAS results were not available, (although analyzed when studying correlations),
these three traits are not present in our final meta-analyses. The reported allele frequencies
were based on GIANT BMI. When the SNP was not studied in GIANT consortium BMI,
then allele frequencies from MAGIC consortium GLUC were used. We also used
bioinformatics approaches for appraising pleiotropy (Methods.6).
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To evaluate the associations between inflammatory markers and MetS risk factors,
seventeen traits were studied. Metabolic traits included were BMI (kg/m2) and WAIST (in
cm) representing domains of adiposity/obesity, for lipids HDLC (mg/dL) and fasting (at
least 8 hours) TG (mg/dL), for glucose metabolism and insulin, fasting INS (mU/L) and
fasting GLUC (mg/dL), for blood pressure SBP and DBP (mm Hg, as average of all three, or
the 2-nd and 3-rd seating blood pressure measures). We use the term “inflammatory
markers” for brevity when referring to the inflammatory – prothrombotic markers.
Inflammatory markers studied were fibrinogen (FIB) (mg/dL) and PAI-1 (IU/mL)
representing prothrombotic markers, and CRP (mg/L), tumor necrosis factor alpha (TNF-
alpha) (pg/mL), ICAM-1 (ng/mL), IL-6 (pg/mL), interleukin 10 (IL-10) (pg/mL), WBCC
(10e9/L) and ADIP (µg/mL) representing markers of immune or inflammatory response.
The studies had a variable number of traits, dependent on the assays performed (Supplement
2). In the study of correlations, because we could not pool individual data from cohorts, we
sought to find the average correlation among all traits for 14 cohorts through two methods,
using simulations and using Fisher’s Z-transformation. The MetS definition, data analyses
methods, adjustments for medications use (for blood pressure and lipids medications) and
covariates were similar for all contributing cohorts and described in Methods.2.
2. MetS definition, variables’ adjustments for medications and other covariates
A participant was classified with MetS when thresholds were passed for three or more out of
five traits of the National Cholesterol Education Program (NCEP) improved threshold [36]:
WAIST ≥ 102 cm for men/WAIST ≥ 88 cm for women; GLUC ≥ 100 mg/dL; TG ≥ 150 mg/dL;
HDLC < 40 mg/dL for men/HDLC < 50 mg/dL for women; SBP ≥ 130 mmHg/DBP ≥ 85
mmHg. The MetS was based on the improved NCEP definition [36] using original traits
adjusted for medication use only (in all cohorts, except for WGHS, which did not measure
GLUC), representing (B) set of data (see Supplemental Tables 9-22). T2D was defined as
following: (GLUC ≥ 126 mg/dL, or using anti-diabetic medications or insulin) and diabetes
onset age ≥ 40 years.
The average blood pressure was adjusted for individuals using antihypertensive
medication(s) as follows, SBP = measured SBP + 15 mmHg; and DBP = measured DBP +
10 mmHg [37]. For individuals using anti-hyperlipidemic medications, their lipid levels
were adjusted respectively as follows, HDLC = measured HDLC/(1+0.04419); and TG =
measured TG/(1−0.17159). For lipids, adjusting constants are produced as a summary of
Wu et al. work [38] and also from our additional unpublished summary follow-up, which
combined together a total of 92 clinical trials (for HMG-CoA reductase inhibitors, Fibric
Acid Derivatives, Cholesterol Absorption inhibitor, Nicotinic acid derivatives, Bile
sequestrants and Fish oil) including 53,005 participants for HDLC and 53,432 participants
for TG. All participating studies set to missing GLUC and INS values for individuals that
were taking insulin or diabetic medications. Before performing any analysis, the
participating studies made sure that each variable had a normal distribution, or transformed
them to near normal. For example, a natural log transformation worked well for TG in
general for all cohorts. In the FamHS, GLUC had a high kurtosis, thus applying a Box-Cox
power transformation it was found, that 1/GLUC2 transformation worked well in acquiring a
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near-normal distributed GLUC. As a result, for any bivariate correlations in the FamHS that
included GLUC, correlations coefficients were multiplied by (−1), because power
transformation for GLUC reversed the sign compared to original corresponding correlations.
As an empirical check, when compared to FHS, the GLUC correlations in FamHS were very
similar, although a transformation of GLUC was implemented in the FamHS. In addition,
phenotypes were adjusted for polynomial age trend (age and age2), sex and important study
specific covariates (e.g. field center), which were included in the regression model if p <
0.05 for generating the final data for analysis: standardized residuals, i.e. with mean 0 and
variance of 1.
In the Supplemental Tables 9-22, we present statistics for individual studies for (A) original
variables, (B) original variables adjusted only for medication use, and (C) residuals from
regression with mean 0 and variance 1 of variables obtained from adjusting (B) data for
additional covariates as mentioned above. In the correlation statistical analyses we use the
standardized final residuals labelled as the (C) set of data.
3. Correlation statistical analysis and simulations
We grouped participants’ data in strata with- and without MetS (M1 versus M0), for
analyzing mean differences of inflammatory markers in these two subgroups for each
cohort. We used (B) data and pooled t-test for testing mean differences between the two: (x̄1
− x̄2), with sample sizes n1 and n2 via , where
 is the pooled standard deviation and n1 + n2 − 2 degrees of
freedom. In general, the MetS subgroup sample size was smaller than non-MetS one, but the
variances between M1 and M0 subgroups were similar. The mean differences of two groups
p-values were tested against a conservative Bonferroni p-threshold for α=0.05 experiment-
wise, which corresponded for 53 tests to a p= 9.43e-04. Statistics of MetS, its risk factors as
well as of inflammatory markers by cohort are summarized in Figure 1 and Supplemental
Figures 1, (a–g). The inflammatory markers boxplot graph comparisons were built by using
simulations via “rnorm” function in R with mean, standard deviation and sample size
corresponding to subgroups with- and without MetS from the original data, (because in this
collaboration we did not have direct access and could not pool original data at the
participants’ level). The above analysis was followed by correlation analyses (including up
to 17 traits), performed with (C) data (defined at the end of Methods.2) near normally
distributed, adjusted for medication use and covariates. All pairwise correlations were
performed using Pearson correlation procedure (using SAS v. 9.3 or R v. 2.15.1, presented
in Supplemental Tables 9-22).
We then used two parallel approaches, simulation and Fisher’s Z-transformation, to
generalize pairwise average correlations over all studies and to confirm our results. First,
simulation processes were implemented to produce the average correlation matrix and the
final correlated simulated data across all studies (N > 85,500 individuals) based on the (C)
set of data. Simulation 1 was performed following these steps: using N (largest number of
participants per study) and variance-covariance matrices (from above single studies) we
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simulated multivariate normal distributions with mean 0 and variance of 1, of dimension (p-
variables, N-participants) for each study, using an R multivariate normal generating
(“mvrnorm”) function of the MASS library [39]. Since in simulations we used the largest
number of participants per study, next, we introduced (in random patterns) missing values in
traits when they were not available in all participants of a specific cohort. Thus, 100
replications of simulated data imitated correlations and sample size of the original cohorts.
When pooled they formed all studies’ set. These data represented all traits, but with
corresponding per trait missing values. Correlations of simulated data were evaluated via
Pearson pairwise correlation, which produced a full variance-covariance matrix,
representing a simulated approximation of the average correlation matrix of single studies.
The covariance matrix (correlations among metabolic traits, metabolic traits and
inflammatory markers, and among inflammatory markers) of simulation 1 are presented in
Table 2. Next, simulation 2 (again 100 replications) were implemented by using the first
simulation’s average variance-covariance matrix, to produce multivariate standardized
normal variables with p = 16 variables and N > 85,500 individuals and no missing values.
Simulation 2 with 100 replications were used to conduct factor analyses.
Second, we performed Fisher’s Z-transformation to average correlations of standardized
final residuals of the (C) set of data (Supplemental Table 2). Assuming that correlations of
any two independent bivariate samples (r1 and r2) of n1 and n2 sample sizes for the same
trait combinations are random samples from a larger population, a combined correlation
estimate (r̄) can be computed. Application of the Z transformation of the two sample
correlations follows: Z1 = tanh−1 (r1) and Z2 = tanh−1 (r2), where tanh is hyperbolic tangent
and the Z can be calculated as , where artanh is hyperbolic
arctangent applied to each correlation coefficient. The weighted average Z̄ of the
corresponding Z values is
where the weights are inversely proportional to their variances (V Z̄ = 1/(n1 + n2 − 6)). Thus,
a combined correlation estimate is r̄ = tanh (Z̄). We extended averaging correlation
coefficients for each bivariate trait combination to include up to 14 cohorts’ correlation
estimations, by writing a SAS macro program that implements Fisher’s Z-transformation
averaging via SAS MIANALYSE procedure. The IL-10 was dropped from these analyses,
because it was present in only one study.
4. Factor analysis
Factor analyses with “Varimax” rotation were performed in SAS, v. 9.3. The purpose of
using a multivariate statistical analysis was to identify latent clusters of traits that may help
in identifying MetS and inflammatory markers underlying etiology. “Varimax” rotation
creates orthogonal clusters of correlated variables. The objective is to maximize the
independence of the clusters of correlated variables that contribute onto specific factors. An
absolute value of a loading 0.4 or larger (which represents a correlation of an original
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variable to a factor when the data are standardized) is considered in the scale of correlations
as a significant contribution. To account for the stochastic process in the 100 simulations,
100 factor analyses (p=16, N > 85,500) with “Varimax” rotation were considered
(Supplemental Figure 2). A coefficient of congruence was calculated as:
, where l1 represents loadings of a factor in a replication
and l2 represents loadings of a similar factor in another replication and ntraits is the number
of traits contributing to a particular factor [40]. This similarity coefficient was calculated for
all similar factors in the 100 replications (respectively 100*99/2=4950 times, as an average
similarity measure of comparable factor configurations in the simulations (Supplemental
Table 3).
The average correlations among eight metabolic traits and nine inflammatory markers
predict to some extent, especially via factor analyses, which trait combinations are useful
and may reflect underlying MetS etiology, out of 130,305 possible trait combinations.
5. Correlated meta-analysis
Pleiotropic effects can result from a single pleiotropic locus (SNP/gene) affecting different
traits, or from a group of alleles at distinct loci (SNPs/genes), but in linkage disequilibrium
(statistical nonindependence) [41]. While examples of studies focused on pleiotropy based
on published results [42, 43], as well as methods on linked pleiotropic loci exist [44, 45], our
study focuses only on single pleiotropic sites (single SNPs) and the corresponding mapped
genes, that associate simultaneously with metabolic traits and inflammatory markers as well
as takes advantage of correlated meta-analyses.
We performed correlation analysis of 8 metabolic traits and 9 inflammatory markers, as a
premise in identifying useful combinations that may help in discovering genetic pleiotropy.
Based on such analysis we had selected 8 trait combinations for follow-up. This large
number of results combined requires an unbiased method for meta-analyzing them. When
meta-component scans are not independent, it can inflate type-I error, since at each location
in the genome, a false-positive finding for one of the scans has an enhanced probability of
being a false positive in any correlated scan. Province, and Province and Borecki [31, 32]
developed a method for correcting bias via a correlated meta-analysis, which only requires
the GWAS results and does not need the individual genotype/phenotype data. The basic idea
is that for a trait of interest, the vast majority of the genome is under the null hypothesis of
no genotype-phenotype association, which is only mildly contaminated with a relatively few
SNPs that are under the alternative. Thus, the method performs sampling of GWAS genome
via the polychoric correlation estimator [46], (using SAS PROC FREQ). It is the estimate of
the NxN correlation matrix, Σ between N scans, that is used to correct the final meta-
estimates for this correlation.
In this article, the meta-analyses were based on p-values combinations, which involved the
Fisher’s 1925 [47] method of combining p-values at each location of the genome [48]. This
technique uses the fact that for N scans, ∑− 2ln (pi) ~ χ2 with 2n degrees of freedom, so the
tail probability provides the meta-analysis p-value. Unfortunately, in the case of correlated
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GWAS, this sum is no longer distributed as a simple chi-square. Instead, in the correlated
meta-analysis method, Province uses an inverse-normal transform, Zi = φ−1 (pi) forming the
N dimensional vector Z of all Zis. He then applies the basic theorem of multidimensional
statistics that for matrix D, if Z ~ N(0, Σ) then D Z ~ N(0, DΣD’). In particular, when D is a
1×N vector of all 1’s, SUM(Z) = D Z ~ N(0, SUM(Σ)), whose tail probability gives the Z
meta-analysis p-value. In this case, for estimating Σ, the SNP p-values are dichotomized
across the genome as (P ≤ 0.5; P > 0.5). The software was developed in SAS by Province
[31] and an interface was built with SAS/InterNet to perform parallel computing of each
meta-analysis within the Division of Statistical Genomics, Washington University
computing cluster.
6. Bioinformatics of selected genes
Another approach we used to appraise pleiotropy was searching Gene Entrez of NCBI
(http://www.ncbi.nlm.nih.gov/gene/) for genes related to each of the traits studied: “body
mass index”, “waist circumference”, “high density lipoprotein cholesterol”, “triglycerides”,
“insulin”, “glucose”, “systolic blood pressure”, “diastolic blood pressure”, “fibrinogen”, “C-
reactive protein”, “plasminogen activator 1”, “interleukin 6”, “interleukin 10”, “intercellular
adhesion molecule 1”, “tumor necrosis factor alpha”, “adiponectin” and “white blood cell
counts”. Our search was limited only to human, mouse and rat species. Identified genes
represent publication evidence of their contribution to a trait based on linkage, association,
function, expression etc. All single traits gene lists were merged by gene name and selected
for most contributions among metabolic traits and inflammatory markers, selected with a
minimum threshold of 8 contributions between the two of them (Supplemental Table 6).
For the same terms, searches were implemented also at www.genome.gov/26525384. These
data represent large genome wide studies with at least 100,000 SNPs and with a high
statistical significance in the overall (initial GWAS + replication) population [49]. Genes
identified as possible candidates were checked via Association Results Browser of dbGaP of
NCBI http://www.ncbi.nlm.nih.gov/projects/gapplusprev/sgap_plus.htm. The same database
was used to identify genes reported to associate with “metabolic syndrome”. Results are
reported in Supplemental Tables 7 and 8. The SNPs were checked if they served as eQTLs
based on the eQTL NCBI database (http://www.ncbi.nlm.nih.gov/gtex/GTEX2/gtex.cgi.
The importance of gene lists identified was mined by means of GeneGO (http://
thomsonreuters.com/products_services/science/systems-biology/) and Literature Lab of
ACUMENTA (http://acumenta.com/) software. The GeneGO, enrichment analysis consists
of matching gene IDs of possible targets for the "common", "similar" and "unique" sets with
gene IDs in functional ontologies in MetaCore, MetaDrug, MetaBase, Specialty modules,
and System toxicology. The probability of a random intersection between a set of IDs the
size of target list with ontology entities is estimated in p-value of hypergeometric
intersection. The lower p-value means higher relevance of the entity to the dataset, which
shows in higher rating for the entity. Literature Lab on the other hand, is an interface
between experimentally-derived gene lists and scientific literature in a curated vocabulary of
24,000 biological and biochemical terms. It employs statistical and clustering analysis on
over 14 million PubMed abstracts (01/01/90 to the present) to identify pathways (809
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pathways), diseases, compounds, cell biology and other areas of biology and biochemistry.
The analysis engine compares statistically the submitted gene set to 1,000 random gene sets
generated on-the-fly to identify term relationships that are associated with the gene set more
than by chance alone.
RESULTS
1. Epidemiological associations between inflammatory markers and MetS
Using data from more than 85,500 participants across 14 cohorts (Table 1.a), we assessed at
the phenotypic level the associations between 9 inflammatory markers CRP, FIB, PAI-1,
IL-6, IL-10, ICAM-1, WBCC, TNFA and ADIP and MetS. Metabolic traits studied were
BMI, WAIST, HDLC, TG, GLUC, INS, SBP and DBP (Supplemental Table 1). The mean
age varied from 25 (SD=±3) years in the CARDIA study to 74 (SD=±8) years in the
Rotterdam Study. These 14 studies capture a range of MetS (NCEP criteria) prevalence,
from 2.4% in the baseline measurement of CARDIA-EA to 58.9% in GENOA-EA. The
prevalence of MetS and its risk factors, as well as the mean levels of inflammatory markers
in individuals with and without MetS, are summarized for two representative studies (the
Family Heart Study and the Framingham Heart Study in Figure 1, and for all cohorts in the
Supplemental Figures 1 (a–g). Overall, when comparing mean levels of inflammatory
markers in individuals with MetS to those without, significant differences (passing
Bonferroni threshold, p ≤ 9.43×10−4) were observed between the two strata in 85% (45 out
of 53) of comparisons. FIB, CRP, PAI-1, ICAM-1, WBCC and TNFA mean levels were
higher, whereas ADIP mean level was lower in individuals with MetS. There were also
exceptions such as IL-10 (present only in one study), which did not show significant mean
differences between individuals with and without MetS.
2. Correlations among metabolic traits and inflammatory markers
We calculated the pair-wise correlations between traits measured within individual studies
(Supplemental Tables 9-22). The generalization of the within-study trait correlation to a
global average correlation matrix was used to prioritize combinations of metabolic traits and
inflammatory markers for subsequent correlated meta-analyses to evaluate the hypothesis of
genetic pleiotropic associations between MetS risk factors and inflammatory markers. The
estimation of average correlations across studies was approached with two methods. First,
we simulated standardized normal variables with mean 0 and variance 1 based on the
correlations and sample size (with missing values) of individual studies, because the original
data at the participant level were not available (Methods.3). The overall average Pearson
pairwise correlations were estimated from 100 replications of simulations with more than
85,500 individuals per replication (Table 2). Second, using Fisher’s Z-transformation
(Methods.3) we combined original correlations of single studies to an overall average
correlation coefficients matrix. The average estimated values of correlation coefficients
resulting from the two methods (Table 2 and Supplemental Table 2) were similar. Pertinent
and significant correlations between inflammatory markers and metabolic traits were (1) FIB
and CRP with all metabolic traits studied; (2) ICAM-1 and TNFA with HDLC and TG; and
(3) ADIP and WBCC with WAIST, HDLC, TG and INS.
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Additionally, based on the overall studies average correlations, we built a second batch of
simulated data for all traits. These simulations had 100 replications, each trait with a mean 0
and standard deviation of 1 with more than 85,500 individuals per replication and this time
with no missing observations. We performed with them factor analyses (Methods.4), which
gave us a second opportunity to identify additional priority combinations of traits as shown
in the Supplemental Figure 2. Factor 1 represented a combination of (4) BMI, WAIST, INS,
CRP, PAI-1 and weaker contributions of HDLC and TG; (5) weak contributions of BMI and
WAIST were associated in Factor 2 with strong contributions of FIB, CRP, IL-6 and
WBCC; (6) TG and less so HDLC, contributed along with CRP and WBCC in Factor 4; (7)
HDLC and TG with PAI1 and ADIP in factor 5, and (8) GLUC and INS contributed to
Factor 6 along with PAI-1. Supplemental Table 3 shows results of the coefficients of
congruence for factors derived across replications (CC, Methods.4). The congruence of
factor 1 across replications was high (CC=0.99). Factor 3 had only contributions from blood
pressure and no noteworthy contributions of inflammatory markers and thus was not
considered for follow-up in the correlated meta-analyses. As a result eight trait clusters were
selected for correlated meta-analyses.
3. Correlated phenotype-GWAS meta-analyses
Finally, we implemented nine correlated meta-analyses (Methods.5), representing eight trait-
combinations predicted from Results.2, and one including all variables. We utilized GWAS
meta-summary-results from individual traits published mainly by large consortia (Table 1.b)
for 8 metabolic traits (BMI [23], WAIST [33], HDLC and TG [24], GLUC and INS [20],
SBP and DBP [22]), and 6 inflammatory markers (CRP [25], PAI-1 [26], ICAM-1 [28],
WBCC [27], ADIP [34] and IL-6 [35]). The significance threshold of meta-analyses was set
at −log10p ≥ 8. In addition, results were filtered requiring at least one metabolic trait and at
least one inflammatory marker had an individual trait significance of −log10p ≥ 3. After
selecting the lead SNP for each locus fulfilling the above three conditions, 130 unique SNPs
remained, each simultaneously associating to at least one metabolic trait and one
inflammatory marker (pleiotropic associations per variant). We infer for each SNP the
corresponding mapped gene underlying such pleiotropic association (Supplemental Table 4).
Of the 130 unique mapped genes, 25 mapped genes were selected as candidates for MetS,
because each corresponding SNP showed at least two associations to metabolic traits from
our analyses or GWAS literature and at least one association with inflammatory markers
(Table 3). The 25 genes represent 15 distinct genomic loci with associations with MetS risk
factors and inflammatory markers. A short description of the known functions of these 25
genes is provided in Table 4, and additional evidence is summarized in Table 5,
Supplemental Table 5 and Figure 2, including annotation from the ENCODE by using
HaploReg [50] and RegulomeDB [51] software and their additional databases.
As shown in Figure 2, specific SNPs based on their pleiotropic associations were classified
in three main groups. The first group of pleiotropic associations for lipids and
inflammation, included a SNP mapped to MACF1 [52] [53] and another SNP mapped to
KIAA0754 on chromosome 1. Both mapped genes associated with HDLC and with WAIST,
TG, GLUC and CRP. Furthermore on chromosome 2, a rich strand (~1.2M bps in length) of
23 contiguous genes, from TCF23 to BRE was associated with TG and CRP. This region
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contains rs1260326 of GCKR, which encodes a missense change Leu446Pro, associated
with both TG [24] and CRP [25]. Another independent group of SNPs on chromosome 2
mapped to genes GRB14 and COBLL1, positioned about 4.7K bps apart and each associated
with HDLC, TG, PAI-1 and ADIP. A SNP near LOC646736 (~23K bps), showed
pleiotropic associations with HDLC, TG and ADIP. The LOC646736 is an uncharacterized
gene on chromosome 2 located ~528K bps from the IRS1 gene. Intronic variants of BAZ1B,
BCL7B, TBL2 and MLXIPL (7q11.23) were associated with TG, HDLC and CRP. An
untranslated variant of LPL (8p22) was associated with HDLC, TG and CRP. TOMM40
(19q13) showed similar phenotypic association patterns. Rs10808546 about 45K bps from
neighboring TRIB1 (8q24.13) was associated with TG, HDLC [24], ADIP and PAI-1. An
intron SNP of ZNF664 (12q24.31) was associated with TG, HDLC and ADIP.
The second group with pleiotropic associations for adiposity/obesity and inflammation
included TFAP2B (6p12), where its corresponding SNP was significantly associated with
BMI, WAIST and CRP; selected SNPs corresponding to HECTD4 (12q24.13) and PTPN11
(12q24) were associated with ICAM-1, DBP, SBP, HDLC, BMI and WAIST, while an
intron variant of FTO (16q12.2) was associated with BMI, WAIST, CRP and INS.
The third group of mapped genes showed pleiotropic associations for adiposity/obesity,
lipids and inflammation. Among them were a missense variant rs13107325 of SLC39A8
(4q22–q24), that associated with HDLC [24], BMI, ADIP, SBP, DBP and WAIST. The
same SNP was previously reported in association with blood pressure, hypertension (HTN)
[54], and BMI [23]. Three SNPs mapping respectively to NELFE, SKIV2L and STK19
(6p21) associated each to TG, BMI, WAIST, SBP, PAI-1 and WBCC. They are located in
the class III region of the major histocompatibility complex of chromosome 6, close to the
C2 gene. An intron SNP of PDXDC1 (16p13.11) was associated with ADIP, WAIST and
TG. Finally, rs6567160 mapped to MC4R (18q22) was associated with BMI, WAIST, CRP,
HDLC and TG.
4. Bioinformatics analyses
We searched the literature for all sources of publications that associated genes with effects
on both metabolic traits and inflammatory markers. If the same gene is published to affect
different traits then it supports the pleiotropy hypothesis. First, keyword searches based on
single trait labels (Methods.6) using Gene Entrez of NCBI produced a list of 770 genes that
had a relationship with at least one of the eight metabolic traits and at least one of the nine
inflammatory markers. Of these, 48 putative pleiotropic genes were ranked with a total
number of ≥ 8 associations with metabolic traits and inflammatory markers keyword
searches, sourced from three species: human, mouse and/or rat (Supplemental Table 6).
Highest ranked for possible pleiotropic effects were the ADIPQ, PPARG and LEP genes. Of
this list through literature search, APOE, FTO, MMP9 and VEGFA overlapped with our 130
pleiotropic gene list (Supplemental Table 4).
A second source of pleiotropic candidate genes was selected from previous GWAS literature
(Methods.6 and Supplemental Table 7). Eleven genes in this list showed association with a
single inflammatory marker, but with up to four associations with metabolic traits. Among
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them, GCKR was associated with four metabolic traits and CRP, while TRIB1 and TOMM40
were associated with HDLC, TG and ADIP and CRP, respectively. With the exception of
CSMD1, the remaining ten genes (GCKR, IRS1, LYPLAL1, TRIB1, APOE, TOMM40,
PPP1R3B, PEPD, BCL7B, TMEM18) are present in the list of 130 pleiotropic candidate
genes of metabolic traits and inflammatory markers.
A third source of pleiotropic candidate genes was the gene search for “metabolic syndrome”
via dbGaP Association Results Browser, which includes findings of the Catalog of
Published Genome-Wide Association Studies (Methods.6). This search yielded 30 MetS
candidate genes (Supplemental Table 8). The overlap: GCKR, C2orf16, ZNF512, TFAP2B,
MLXIPL, LPL, TRIB1, MTNR1B, FTO, TOMM40, represents 33% of the Browser MetS list
and 7.7% of our 130’ genes pleiotropic list (Supplemental Table 4).
GeneGO database pathway analysis was performed for our 130 candidate pleiotropic genes.
The pathway map of “ZNF202 role in gene expression in atherosclerosis”, was enriched for
genes affecting lipid metabolism (p=7.0×10−8), while less significant p-values were for
other pathways. For process networks, the most common were those related to
inflammation. Since HLA genes are quite enriched in these pathways, removal of 7 genes,
whose names started with HLA, produced a list of 123 pleiotropic candidate genes. The
pathway maps remained similar as above, however process networks changed to
“Complement system” (Inflammation, p= 5.7×10−4), and “Blood vessel morphogenesis”
(Development, p= 1.2×10−3). For the disease classification, GeneGO reports the top ranking
diseases as “Metabolic Syndrome” (p= 1.2×10−12, TRIP8, BMAL1, GCKR, C2orf16, LPL,
MMP-9, HNF4-alpha, NTPBP, APOE, TRIPs, TFAP2A, ZNF512, VEGF-A, AP-2B, MC4R,
Notch, RGPR, Galpha(s)-specific peptide GPCRs, FTO, HNF4, CCDC121), Obesity (p=
6.1×10−11), “Coronary disease” (p= 1.6×10−8), “Macular degeneration” (p= 3.7×10−8) and
T2D (p= 7.5×10−8). In the GO processes, “Glucose homeostasis” (p= 3.0×10−9), “Positive
regulation of vascular permeability” (p= 8.8×10−9) and “Regulation of insulin secretion” (p=
4.0×10−7) were ranked at the top.
The following gene list GCKR, TFAP2B, MLXIPL, LPL, TRIB1, FTO, TOMM40 represents
23% of Browser MetS list and 28% of our 25 MetS pleiotropic candidates (Table 3).
Bioinformatic analysis using GeneGO database for our 25 MetS candidate genes shows that
only a few contribute to the GeneGO Canonical pathway maps. PTPN11 and GRB14 are up-
regulated, part of the “Development Angiopoietin Tie2 signaling” (enrichment p= 2.4E-04),
conveying anti-inflammatory action. PTPN11 is part of six other pathways, while LPL is
part of three pathways. GeneGO enrichment analysis ranked as the top diseases “Metabolic
Syndrome” (p= 9.0×10−7); “Obesity” (p= 8.5×10−7); and “Insulin Resistance” (p=
5.6×10−7). From our list, some of the genes also have been studied for pharmacologic
applications. LPL is a therapeutic drug target for ibrolipim (activation) and gemfibrozil
(activation), while MC4R is a target for bremelanotide (activation) and PTPN11 is a target
for stibogluconate (inhibition).
Using the Literature Lab software of ACUMENTA Biotech for an automated literature
interrogation [55], the same list of 25 genes showed association, compared with 1000
random sets of genes, for overnutrition (p=0.0039), obesity (p=0.0041), nutrition disorders
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(p=0.0053), heart valve diseases (p=0.0112), and fatty liver (p=0.0124). The contributing
genes in these disease-MeSH term clusters, ranked by the number of the corresponding
publications, were for overnutrition: MC4R (46.3%), FTO (42.4%), LPL (10.4%) and
MLXIPL (0.6%); similar genes were in ranking order for obesity and nutrition disorders; for
heart valve diseases BAZ1B (47.0%), PTPN11 (37.5%), TBL2 (7.7%), and BCL7B (6.6%);
and for fatty liver MLXIPL (89.5%), LPL (8.0%) and GCKR (1.8%).
DISCUSSION
This is the first time that a large sample of more than 85,500 participants with 8 metabolic
traits and 9 inflammatory markers is analyzed together with the purpose of understanding
relationships of inflammatory markers and MetS. Mean levels of inflammatory markers FIB,
CRP, PAI-1, ICAM-1, WBCC and TNFA were higher, while mean ADIP level was lower in
individuals classified with MetS compared to those without. These differences reached
statistical significance. We explored the pairwise average correlations of all traits over all 14
studies. Correlation estimates and factor analyses yielded eight trait-combinations out of
130,305 possible combinations between metabolic traits and inflammatory markers, which
may reflect some of the genetic correlations.
This is also the first time that 8 metabolic traits and 6 inflammatory markers mainly from
large consortia meta-analyses are used to search for pleiotropic associations between MetS
and inflammation. The analyses yielded 130 top ranked mapped genes with putative
pleiotropic associations among metabolic traits and inflammatory markers. Twenty-five
variants with pleiotropic associations, each mapped by a single gene, were considered as
contributors to MetS per se. We considered MetS candidate genes to be the ones associated
with two or more MetS risk factors (from our study and GWAS literature), and with one or
more inflammatory markers.
Based on these analyses we infer that a pleiotropic genetic architecture exists and
contributes to MetS. But what exactly do we see as pleiotropy at the gene level? Here we
focus on a cluster of genes located on 7q11.23. At first glance, genes BAZ1B, BCL7B, TBL2
and MLXIPL, show pleiotropy by similarly associating TG, HDLC and CRP. A few SNPs of
BAZ1B were associated with TG [56], protein C [57], and serum urate concentration [58].
BCL7B’s SNPs were associated with CRP [25] and with gamma-Glutamyltransferase [59].
TBL2 was associated with TG [24, 60, 61] and with HDLC [24]. MLXIPL was associated
significantly with very low density lipoprotein (VLDL) [62], with MetS [63], with TG [64],
and with gamma-Glutamyltransferase [65] (Table 5 and Supplemental Table 5). Deletions of
the four above contiguous genes have been identified as causing a Williams-Beuren
syndrome, a multisystem developmental disorder, where 75% of cases show severe GLUC
intolerance [66]. BAZ1B and MLXIPL may serve as transcription factors. The rs17145750 of
MLXIPL, based on regulomeDB shows some minimal regulatory signature, and from
HaploReg software affects a PPAR motif [50]. The rest of the selected SNPs also have some
minimal regulatory properties. The majority of the SNPs in the four genes are under two
overlapping linkage disequilibrium blocks (HapMap figure not shown). It has been reported
that MLXIPL protein forms a heterodimeric complex and activates, in a glucose-dependent
manner, carbohydrate response element (ChoRE) motifs in the promoters of triglyceride
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synthesis genes. Thus, MLXIPL plays a critical role in systemic glucose metabolism, by
converting excess carbohydrates to TG by way of de novo lipogenesis [66–68]. Recently,
Herman et al. [69] showed in mice that GLUT4, officially known as SLC2A4 (known to be
used by insulin for stimulating glucose uptake), regulates the expression of MLXIPL.
Donnelly et al. [70] studied 9 non-alcoholic fatty liver disease participants (with excess liver
TG) and showed that about 26% of TG in the liver was result of de novo lipogenesis, 59%
from serum nonesterified fatty acids, 15% from diet, and a similar pattern of isotope
labelling in VLDL. Thus, concluding that de novo lipogenesis contributes to the
accumulation of hepatic fat. Jeong et al. [71], studied expression of MLXIPL using ChIP-seq
and identified 14 genes as direct targets that affect the paths from GLUC to TG. They also
proposed that MLXIPL is an activator and repressor based on gene expression patterns of
target genes. The role of MLXIPL is complex, because in C57BL/6 mice, global deficiency
of MLXIPL leads to insulin resistance [67], while in obese mouse with ob/ob background
(leptin deficiency) [67] leads to improved hepatic steatosis and improved insulin resistance.
Moreover, Benhamed at al. [66] proposed that MLXIPL in the mouse liver raises beneficial
lipid species. Thus, the pleiotropic associations of MLXIPL are complex and context-
dependent.
Our findings are supported by additional GWAS results for several genes of three major
pleiotropic groups presented in Figure 2. A comprehensive GWAS and functional evidence
is reported in Tables 4, 5 and Supplemental Table 5 as evidence supporting our findings
grouped by pleiotropic genes for 1) lipids and inflammation, 2) adiposity/obesity and
inflammation, and 3) lipids, adiposity/obesity and inflammation [12, 24, 34, 59, 63–65, 72–
122]. The power achieved by our study is owing to the use of the world’s largest GWAS
meta-analyses available (Table 1.b). Because results originate from different consortia, it is
possible that studies included may overlap subjects for different traits. However, the
approach of correlated meta-analysis we use corrects results if such correlation is present
(Methods.5). Previous studies have shown that risk of MetS, is influenced by genes that
affect individual MetS risk factors [30, 63].
An appealing characteristic of the 130 pleiotropic candidates (Supplemental Table 4) is that
several mapped genes are particularly associated with adiponectin and HDLC. Studies have
shown that HDLC is a critical risk factor for coronary heart disease. In four studies, an
increase by 1 mg/dL in HDLC associated with 2–3% decrease in coronary heart disease risk
[123]. Large analyses, also support the importance of HDLC measurement in the risk
assessment of heart disease [124, 125]. In parallel, increased levels of adiponectin are of
interest. For example, Ye and Scherer [126] summarized effects of adiponectin by reviewing
either recombinant adiponectin protein, or endogenously its overproduction. In adipose
tissue, adiponectin lowers inflammation and increases glucose uptake, fat storage and
adipogenesis; in muscle induces an increased fatty acid oxidation; in heart decreases injury
and apoptosis; in endothelium decreases oxidative stress and increases angiogenesis and
function; in liver increases insulin sensitivity and lowers gluconeogenesis and lipogenesis; in
macrophages increases insulin sensitivity and lowers inflammation. Thus it remains to be
investigated, if SNPs with pleiotropic associations to the two phenotypes HDLC and
adiponectin are flagging any anti-inflammatory and/or MetS protective effects from these
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genes (LYPLAL1, GRB14, COBLL1, STAB1, NT5DC2, FAM13A, SLC39A8, ARL15,
VEGFA, HCAR2 [127], ZNF664, CMIP [128], and PEPD [120, 129, 130]).
In the list of 130 pleiotropic genes, a few special patterns emerged. The SNPs reported in
Supplemental Table 5 closer to LOC646736 and a little more distant to IRS1 gene appear not
to be eQTLs of IRS1 based on the NCBI database (Methods.6). Co-localization might relate
with evolutionary functional importance, which is observed in our data for gene clusters. For
example, a missense SNP (rs1260326, T=0.3963) of GCKR associated with similar traits as
rs1919127 (C=0.2647) a missense of C2orf16, also as rs23844656 (G=0.2642), an intron of
ZNF512 and rs13002853 (G=0.2593) a variant of CCDC121; another cluster was for
DNAH10, CCDC92, and ZNF664 on chromosome 12, and for HNF4A, PLTP, PCIF1,
ZNF335 and MMP9 on chromosome 20. Such clustering patterns are similar to a pattern
previously reported on chromosome 11 for APOA5, ZNF259, and BUD13, where a zinc
finger protein probably controls the transcription of nearby genes [80]. It is possible that
neighboring gene-variants produce similar results in the associations, because of conserved
haplotypes. In the 130 pleiotropic genes, 11 transcription factors (HEYL, SEC16B, GTF3C2,
ZNF512, GTF2H4, TFAP2B, BAZ1B, MLXIPL, ZNF664, MED24, HNF4A and ZNF335)
represent about 8.5% of the list. Vaquerizas et al. [131] reported 1,391 high confidence loci
that encode transcription factors, about 6% of the total of human protein coding genes. Thus
the 130-genes’ list shows patterns that might be common for function conservation. Another
feature observed by comparison of 130 pleiotropic candidate genes with the 30 MetS
candidate genes (Supplemental Table 8) was that, although APOA5 and its cluster, as well as
CETP, LIPC, GALNT2 involved in lipid metabolism are considered contributors to MetS,
based on our results they appear not associated directly with inflammation.
The present results suggest that pleiotropic genes play a role in MetS. About two-thirds of
our 25 MetS pleiotropic candidates have not previously implicated for MetS risk. Mapped
loci represent MACF1& KIAA0754, GRB14& COBLL1& LOC646736-IRS1, SLC39A8,
NELFE & SKIV2L & STK19, BAZ1B& BCL7B& TBL2 & MLXIPL, HECTD4& PTPN11,
and ZNF664, where MLXIPL is already published for its association with MetS with a p-
value < 0.01 [63]. They represent known loci identified as having multiple relationships at
the level of single traits or T2D or CHD and not previously fully appreciated for their
genetic pleiotropy. These findings summarized in Figure 2, reinforce the importance of
inflammatory responses as correlates of MetS and suggest that pleiotropic loci and their
pathways contribute to the correlated architecture of MetS.
Kristiansson et al. [63] replicated 22 previously identified susceptibility loci for individual
MetS risk factors, when testing for associations with MetS individual risk factors or with
orthogonal factors from factor analysis. Most of the identified loci associated with lipid
phenotypes and none were associated with two or more orthogonal MetS factors. Also they
did not find evidence of pleiotropy of these genes with obesity. By comparison, our study
based on very large GWAS meta-analyses indicates, that some MetS genes may be
associated with two or more MetS risk factors, including inflammatory markers. For
example, MC4R (rs6567160) showed associations with WAIST, BMI, HDLC, TG and CRP;
NELFE (rs419788), SKIV2L (rs437179), STK19 (rs389883) were associated with TG,
WAIST, SBP, PAI-1, WBCC, and BMI; SLC39A8 (rs13107325) was associated with
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HDLC, BMI, WAIST, SBP, DBP and ADIP; and MACF1 (rs1537817) was associated with
HDLC, CRP, TG, WAIST, and GLUC.
The bioinformatic research provided additional information not only in support to our
findings, but also to a finer understanding of gene effects as is the case of BAZ1B, PTPN11,
TBL2, BCL7B for heart valve disease, and MLXIPL, LPL and GCKR in relation to fatty liver
disease as revealed by the Literature Lab. In contrast, our literature Entrez gene search based
on trait keywords produced a filtered list of 48 pleiotropic candidate genes (Supplemental
Table 6), from human, mouse and/or rat research. The 48 genes’ list can reflect also
weakness. For example, if a gene association/effect is identified from a single study with a
small sample size, the keyword search still considers it as a countable contribution.
Regardless of this weakness, keyword searches revealed that other genes with pleiotropic
effects among metabolic traits themselves and also with inflammation remain to be
discovered.
In principle, genetic makeup and environment contribute to the occurrence of MetS, whereas
total burden is related to number and direction of disease predisposing alleles one carries.
Our inferences are based on meta-analyses of p-values, and do not account for direction of
associations for each SNP across studies (because some studies did not share beta-s and
corresponding standard errors). This may represent a weaknesses in our study, for it could
produce significance with heterogeneity. To diminish false positives we filtered our results
for associations based on a meta −log10p ≥ 8 and requiring individual associations of
metabolic traits and inflammatory markers to have single trait-single SNP associations with
−log10p ≥ 3. We worked only with association GWAS meta-results mainly of large
consortia, and because of not having access to raw data, it was not possible to evaluate
mediation [132, 133]. Because of large GWAS samples used, we expect follow up with
functional tests can further elucidate the role of pleiotropy in MetS. In conclusion, several
inflammatory markers are indeed part of metabolic syndrome. A pleiotropic genetic
architecture exists and contributes to MetS. Among genes with pleiotropic associations in
our study, specific alleles of the ones associating with ADIP and HDLC may further
contribute in understanding how to protect from MetS.
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• Analyzed 17 metabolic and inflammatory traits in > 85,500 participants from 14
studies
• Big data evidenced that inflammation is a feature of metabolic syndrome (MetS)
• Performed meta-analyses of large GWAS for 8 metabolic and 6 inflammatory
traits
• Of the 130 pleiotropic variants identified, 25 are proposed to contribute to MetS
• Pleiotropy across MetS risk factors reflects in its correlated genetic architecture
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Prevalence of MetS and its components and mean levels of inflammatory markers in
individuals classified with and without MetS (M1 vs. M0).
Footnote: Top histogram numbers represent prevalence (%) of MetS, T2D and MetS
components. Bottom numbers represent number of participants for a particular trait. The
inflammatory marker boxplot graph comparisons were built by using “rnorm” function in R
with mean, standard deviation and sample size corresponding to subgroups with and without
MetS from original (B) data. Overall, they represent 53 tests of inflammatory markers per
MetS strata, summarized in Supplemental Figures 1(a–g). The number within each pair of
boxplots marked by “D=” is the difference of two means of an inflammatory marker in
groups of participants classified with versus without MetS. The light yellow boxed number
at the bottom of the same graph marked with “pt=” represents a p-value calculated by pooled
t-test for testing if their means (M1 vs. M0) are different. In case the color of pt-value box is
gray, then the p-value does not pass the Bonferroni threshold p=9.43e-04.
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A network of 25 pleiotropic genes with putative contributions to MetS, including
inflammation.
Footnote: In the figure they connect by GWAS phenotypic evidence and whether selected
SNPs show any regulatory features based on the ENCODE database as implemented via
HaploReg [50]/RegulomeDB [51] software. All phenotypic labels correspond to
associations reported in the Results, Discussion, Table 5 and Suppplemental Table 5.
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Table 5
A short summary of additional supportive findings for the 25 MetS pleiotropic candidates
Group 1: Pleiotropic genes for lipids and inflammatory markers
• The MACF1 was also associated with T2D (Albrechtsen et al., 2013). Recently, Fassett et al. (2013) using inducible cardiac-specific MCF1
knockout mice concluded this gene works as a stress induced regulator of cardiomyocyte microtubule distribution and is important for
ventricular adaptation to hemodynamic overload. • The GCKR rs1260326 was associated with T2D risk, by changing the ability of GCKR to
sequester glucokinase in the nucleus of hepatocytes (Rees et al., 2012), and with hepatic fat accumulation along large VLDL and TG levels in
obese youth (Santoro et al., 2013). Rees et al., 2012), suggested that leucine allele elevates hepatic glucose uptake and disposal by increasing
active cytosolic GCK, which would increase hepatic lipid biosynthesis. Another GCKR SNP was associated with serum albumin (Kim et al.,
2012), decreased levels of amino acids alanine and isoleucine and elevated levels of glutamine (Stancakova et al., 2012), with liver enzyme
gamma-Glutamyltrasferase (Chambers et al., 2011), and platelet count (Gieger et al., 2011). GCKR was associated with serum calcium
(O’Seaghdha et al., 2013). GCKR has already been proposed as a candidate for MetS for its significant associations with qualitative bivariate
TG-BP and WC-TG (Kraja et al., 2011). The rs2303369, neighboring GCKR and an intron of fibronectin type III (FNDC4) was associated
significantly with menopause (Stalk et al., 2012). • The GRB14 protein has a pleckstrin homology domain, a C-terminal Src homology 2 (SH2)
domain, and an intervening ~45 residues known as BPS. GRB14 and its family members GRB7 and GRB10 are recruited by a number of
receptor tyrosine kinases (Depetris et al., 2005). This recruitment is facilitated via phosphotyrosine binding the SH2 domain, while the INS and
IGF1 receptors are recruited by the BPS region (Cariou et al., 2004). Cooney et al. (2004) noticed an improved glucose tolerance and an
enhanced insulin-induced signaling in muscle and liver, but not in adipose tissue in a male mice deficient for Grb14 (−/−). They proposed that
Grb14 was a negative regulator, tissue specific for insulin signaling. In a gene expression study, Grb14 expression was elevated in adipose
tissue of both ob/ob mice and Goto-Kakizaki (non-obese T2D) rats (Cariou et al., 2004). Our meta-analyses results add to the importance of
GRB14, which can be viewed as an inhibitor of the insulin receptor and therefore as affecting insulin signaling. • The COBLL1 (Carroll et al.,
2003) was associated with T2D (Albrechtsen et al., 2013). Adjacent to this gene toward GRB14 are a number of SNPs that were associate with
T2D (Kooner et al., 2011), TG (Teslovich et al., 2010) and HDLC (Teslovich et al.,2010). Albrechtsen et al. (2013) showed that COBLL1
expresses in pancreatic islets and kidney, and to some degree in skeletal muscle, liver and adipose tissue. They stipulated COBLL1 variants may
influence expression of nearby GRB14 to change insulin sensitivity. • The LOC646736 rs2943634 was associated with coronary disease
(Samani et al., 2007) and T2D (Rung et al., 2009). Downstream (~47K bps) from this SNP, an intron of LOC646736 was associated with T2D
(Voight et al., 2010). Upstream of our meta-SNP, a few SNPs associates with TG (Teslovich et al.,2010), with adiposity (Kilpelainen et al.,
2011), and with ADIP (Dastani et al., 2012). • The LPL is significantly associated with TG and HDLC (Several studies confirm these
associations). LPL is part of glycerolipid metabolism pathway (map00561, kegg.jp), involved in free fatty acids production, and is also a
member of PPAR signaling pathway (map03320, kegg.jp). • The TRIB1 is reported in associations with TG, HDLC, LDLC (Teslovich et al.,
2010), with alkaline phosphatase and alanine transaminase (Chambers et al., 2011), with ADIP (Dastani et al., 2012), with Crohn’s Disease
(Barret et al., 2008), with bivariate qualitative combinations of HDLC-TG and TG-BP (Kraja et al., 2011). Recently Akira et al. (2013)
working with Trib1(−/−) mice demonstrated that mice lacking Trib1 in hematopoietic cells exhibited severe lipodystrophy due to increased
lipolysis, while in a high-fat diet, mice exhibited hypertriglyceridemia, insulin resistance, together with increased proinflammatory cytokine
production. They suggested, that Trib1 is critical for adipose tissue maintenance and suppression of metabolic disorders by controlling the
differentiation of tissue-resident anti-inflammatory-like macrophages. The rs10808546 positioned about 45K bps from TRIB1 is located in a
DNAase mark often found in active regulatory elements. • The ZNF664 associates with visceral adipose tissue adjusted for BMI and with
visceral adipose tissue/subcutaneous adipose tissue ratio for women (Fox et al., 2012). • TOMM40 SNPs are in linkage disequilibrium with
APOE SNPs (HapMap LD plot not shown). TOMM40 is positioned at the side of the cluster APOE/APOC4/APOC2 and was associated with
Alzheimer’s disease (Harold et al., 2013; Seshadri et al., 2010), low density lipoprotein cholesterol (LDLC) and HDLC (Aulchenko et al.,
2009) and CRP (Aulchenko et al., 2009; Reiner et al., 2008). The rs2075650 of TOMM40 is part of three signatures of promoter histone marks,
part of enhancer histone markers in 6 cell types, it can be involved in a DNase signature, and is part of 8 changed motifs, among them sterol
regulatory element binding transcription factor (SREBP).
Group2: Pleiotropic genes for adiposity/obesity and inflammation
• An intron of TFAP2B, was associated with the effects of dietary fat intake on weight loss and waist reduction (Stocks et al., 2012). A few
other SNPs of TFAP2B associated significantly with BMI (Speliotes et al., 2010), adiposity (Lindgren et al., 2009) and with a qualitative
bivariate WAIST-GLUC combination (Kraja et al., 2011). • The PTPN11 was associated with platelet counts (Soranzo et al., 2009), with TG
(Kathiresan et al., 2007), and with carotid arteries (O’Donnell et al., 2007). • While FTO contributes to the regulation of the global metabolic
rate, energy expenditure, energy homeostasis, regulation of body size and body fat accumulation, its exact function is not known. Other SNPs
of FTO were associated with BMI (Sepliotes et al., 2010), body weight (Thorleifson et al., 2009), adiposity (Kilpelainen et al., 2011), WAIST
(Heard-Costa et al., 2009), with T2D (Zeggini et al., 2007) and less so with factor1 and factor2 of MetS risk factors (Kristinansson et al., 2012).
Group 3: Pleiotropic genes for adiposity/obesity, lipids and inflammation
• The SLC39A8 protein is found in the plasma membrane and mitochondria, and functions in the cellular transport of zinc at the onset of
inflammation. SLC39A8 is a negative regulator of NF-κB and functions to negatively regulate proinflammatory responses through zinc-
mediated down-modulation of IκB kinase (IKK) activity (Liu et al., 2013). SLC39A8 and SLC39A14 are regulated by IL-6 dependent signaling
in the liver (Liuzzi et al., 2005). In addition, rs230487, which is closer to NFKB1 than SLC39A8 was associated with tissue Plasminogen
activator (Yang et al., 2007). Liu et al. (2013) proposed that SLC39A8 and SLC39A14 are important zinc transporters that channel zinc in a
tissue-specific manner to fundamentally important intracellular checkpoints, which help to coordinate and balance host defense. • The NELFE,
SKIV2L and STK19 position in the class III region of the major histocompatibility complex of chromosome 6. The three genes are likely
involved in transcription regulation and have been found to be associated with Macular Degeneration and Lupus Erythematosus, and
rs2072633, an intron of CFB – complement factor B, (but only 286 bps from NELFE gene) (International, 2007) being associated with Multiple
Sclerosis. • The association of PDXDC1 with ADIP may indicate that its pleiotropic effect could have protective contributions for inflammation
and MetS. Based on the ENCODE information the rs4985155 is located in a transcription factor binding site and corresponds to a DNase peak
(based on HaploReg (Ernst et al., 2011) and regulomeDB (Boyle et al., 2012) software). The rs4500751, (chr16:15140211) mapped at NTAN1
about 10.7K bps from our PDXDC1 meta-SNP, associated with absolute plasma levels and proportions of the phospholipid species with
important roles in cell survival and inflammation (Demirkan et al., 2012). Other SNPs associated with blood metabolite concentration (Suhre et
al., 2011), and with phospholipids levels in plasma (Lemaitre et al., 2011).
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• The MC4R is a member of melanocortin family. The melanocortins are involved in pigmentation, energy homeostasis, inflammation,
immunomodulation, steroidogenesis and temperature control. Stäubert et al. (2007) found a strong correlation between positional conservation
and the functional relevance of missense, nonsense, and frame-shifting mutations of MC4R affecting 60 amino acid positions. The mostly
heterozygous (dominant) occurring MC4R mutations are implicated in 1–6% of early-onset or severe adult obesity cases. Some of the GWAS
findings indicated that MC4R was associated with BMI (Speliotes et al., 2010; Willer et al., 2009), obesity (Meyre et al., 2009), body height
(Lango et al., 2010), with body weight (Thorleifsson et al., 2009), WAIST (Chambers et al., 2008), and with HDLC (Teslovich et al., 2010).
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